| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.5 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.1 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.036 | 0.5 |